These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 12019161

  • 1. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
    Uchimiya H, Furukawa T, Okamoto M, Nakajima Y, Matsushita S, Ikeda R, Gotanda T, Haraguchi M, Sumizawa T, Ono M, Kuwano M, Kanzaki T, Akiyama S.
    Cancer Res; 2002 May 15; 62(10):2834-9. PubMed ID: 12019161
    [Abstract] [Full Text] [Related]

  • 2. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.
    Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, Akiba S, Miyadera K, Fukushima M, Yamada Y, Yoshida H, Kanzaki T, Akiyama S.
    Cancer Res; 1999 Apr 15; 59(8):1911-6. PubMed ID: 10213500
    [Abstract] [Full Text] [Related]

  • 3. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S, Saga Y, Suzuki N, Fujioka A, Nakagawa F, Fukushima M, Suzuki M.
    Int J Oncol; 2003 May 15; 22(5):961-7. PubMed ID: 12684660
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose.
    Nakajima Y, Gotanda T, Uchimiya H, Furukawa T, Haraguchi M, Ikeda R, Sumizawa T, Yoshida H, Akiyama S.
    Cancer Res; 2004 Mar 01; 64(5):1794-801. PubMed ID: 14996742
    [Abstract] [Full Text] [Related]

  • 5. 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9.
    Nakajima Y, Haraguchi M, Furukawa T, Yamamoto M, Nakanishi H, Tatematsu M, Akiyama S.
    Int J Cancer; 2006 Oct 01; 119(7):1710-6. PubMed ID: 16646076
    [Abstract] [Full Text] [Related]

  • 6. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.
    Stevenson DP, Milligan SR, Collins WP.
    Am J Pathol; 1998 Jun 01; 152(6):1641-6. PubMed ID: 9626068
    [Abstract] [Full Text] [Related]

  • 7. Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-D-ribose.
    Ikeda R, Furukawa T, Kitazono M, Ishitsuka K, Okumura H, Tani A, Sumizawa T, Haraguchi M, Komatsu M, Uchimiya H, Ren XQ, Motoya T, Yamada K, Akiyama S.
    Biochem Biophys Res Commun; 2002 Mar 08; 291(4):806-12. PubMed ID: 11866437
    [Abstract] [Full Text] [Related]

  • 8. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
    Yu EJ, Lee Y, Rha SY, Kim TS, Chung HC, Oh BK, Yang WI, Noh SH, Jeung HC.
    Mol Cancer Res; 2008 Oct 08; 6(10):1554-66. PubMed ID: 18922971
    [Abstract] [Full Text] [Related]

  • 9. 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression.
    Nakajima Y, Madhyastha R, Maruyama M.
    Anticancer Agents Med Chem; 2009 Feb 08; 9(2):239-45. PubMed ID: 19199868
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.
    Hotchkiss KA, Ashton AW, Klein RS, Lenzi ML, Zhu GH, Schwartz EL.
    Cancer Res; 2003 Jan 15; 63(2):527-33. PubMed ID: 12543812
    [Abstract] [Full Text] [Related]

  • 11. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
    Miszczak-Zaborska E, Smolarek M, Bartkowiak J.
    Postepy Biochem; 2010 Jan 15; 56(1):61-6. PubMed ID: 20499682
    [Abstract] [Full Text] [Related]

  • 12. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.
    Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, Miyadera K, Yamada Y, Aikou T, Akiyama S.
    Biochem Biophys Res Commun; 1998 Dec 30; 253(3):797-803. PubMed ID: 9918807
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.
    Akiyama S, Furukawa T, Sumizawa T, Takebayashi Y, Nakajima Y, Shimaoka S, Haraguchi M.
    Cancer Sci; 2004 Nov 30; 95(11):851-7. PubMed ID: 15546501
    [Abstract] [Full Text] [Related]

  • 16. [Thymidine phosphorylase and angiogenesis].
    Akiyama S.
    Gan To Kagaku Ryoho; 2000 Jul 30; 27(8):1208-11. PubMed ID: 10945018
    [Abstract] [Full Text] [Related]

  • 17. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
    Xiao YS, Zhou J, Tang ZY, Fan J, Wu ZQ, Liu YK, Ye SL, Shen ZZ, Xue Q, Zhao Y.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3205-9. PubMed ID: 16405841
    [Abstract] [Full Text] [Related]

  • 18. Thymidine phoshorylase as a target for antiangiogenesis treatment.
    Peters GJ, Bijnsdorp IV, Fukushima M.
    Nucleic Acids Symp Ser (Oxf); 2008 Nov 30; (52):629. PubMed ID: 18776537
    [Abstract] [Full Text] [Related]

  • 19. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study.
    Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL.
    J Pathol; 1995 Jun 30; 176(2):183-90. PubMed ID: 7636628
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.